Detalhe da pesquisa
1.
Recombinant ADAMTS13 in Congenital Thrombotic Thrombocytopenic Purpura.
N Engl J Med
; 390(17): 1584-1596, 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38692292
2.
Peak ADAMTS13 activity to assess ADAMTS13 conformation and risk of relapse in immune-mediated Thrombotic Thrombocytopenic Purpura.
Blood
; 2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38502824
3.
Delayed normalization of ADAMTS13 activity in acute thrombotic thrombocytopenic purpura in the caplacizumab era.
Blood
; 141(18): 2206-2213, 2023 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36720103
4.
Long-term risk of relapse in immune-mediated thrombotic thrombocytopenic purpura and the role of anti-CD20 therapy.
Blood
; 141(3): 285-294, 2023 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-36322971
5.
Real-world use of thrombopoietin receptor agonists for the management of immune thrombocytopenia in adult patients in the United Kingdom: Results from the TRAIT study.
Br J Haematol
; 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38429869
6.
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination.
N Engl J Med
; 384(23): 2202-2211, 2021 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33861525
7.
Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis.
N Engl J Med
; 385(18): 1680-1689, 2021 10 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34379914
8.
Clinical features of thrombosis and bleeding in COVID-19.
Blood
; 140(3): 184-195, 2022 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35452509
9.
Natural history of PF4 antibodies in vaccine-induced immune thrombocytopenia and thrombosis.
Blood
; 139(16): 2553-2560, 2022 04 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35263420
10.
A 'needle in a haystack': Drug-induced thrombotic thrombocytopenic purpura-Association or causality?
Br J Haematol
; 201(4): 599-601, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36661238
11.
Redefining outcomes in immune TTP: an international working group consensus report.
Blood
; 137(14): 1855-1861, 2021 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33529333
12.
Real-world experience with caplacizumab in the management of acute TTP.
Blood
; 137(13): 1731-1740, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33150355
13.
The use of obinutuzumab and ofatumumab in the treatment of immune thrombotic thrombocytopenic purpura.
Br J Haematol
; 198(2): 391-396, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35430727
14.
Von Willebrand factor assays in patients with acquired immune thrombotic thrombocytopenia purpura treated with caplacizumab.
Br J Haematol
; 197(3): 349-358, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35262910
15.
Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study.
Lancet
; 398(10306): 1147-1156, 2021 09 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34370972
16.
Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura.
N Engl J Med
; 380(4): 335-346, 2019 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-30625070
17.
Thrombus Distribution in Vaccine-induced Immune Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.
Radiology
; 305(3): 590-596, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35699579
18.
Management of thrombotic microangiopathy in pregnancy and postpartum: report from an international working group.
Blood
; 136(19): 2103-2117, 2020 11 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32808006
19.
Identification of a novel genetic locus associated with immune-mediated thrombotic thrombocytopenic purpura.
Haematologica
; 107(3): 574-582, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33596643
20.
European Renal Best Practice endorsement of guidelines for diagnosis and therapy of thrombotic thrombocytopaenic purpura published by the International Society on Thrombosis and Haemostasis.
Nephrol Dial Transplant
; 37(7): 1229-1234, 2022 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35195251